Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications
- PMID: 21044213
- PMCID: PMC2974339
- DOI: 10.1111/j.1549-8719.2010.00051.x
Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications
Abstract
Arterial occlusive disease is the leading cause of morbidity and mortality throughout the developed world, which creates a significant need for effective therapies to halt disease progression. Despite success of animal and small-scale human therapeutic arteriogenesis studies, this promising concept for treating arterial occlusive disease has yielded largely disappointing results in large-scale clinical trials. One reason for this lack of successful translation is that endogenous arteriogenesis is highly dependent on a poorly understood sequence of events and interactions between bone marrow derived cells (BMCs) and vascular cells, which makes designing effective therapies difficult. We contend that the process follows a complex, ordered sequence of events with multiple, specific BMC populations recruited at specific times and locations. Here, we present the evidence suggesting roles for multiple BMC populations-from neutrophils and mast cells to progenitor cells-and propose how and where these cell populations fit within the sequence of events during arteriogenesis. Disruptions in these various BMC populations can impair the arteriogenesis process in patterns that characterize specific patient populations. We propose that an improved understanding of how arteriogenesis functions as a system can reveal individual BMC populations and functions that can be targeted for overcoming particular impairments in collateral vessel development.
© 2010 John Wiley & Sons Ltd.
Figures



Similar articles
-
Arteriogenesis versus angiogenesis in peripheral artery disease.Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:27-9. doi: 10.1002/dmrr.2232. Diabetes Metab Res Rev. 2012. PMID: 22271719 Review.
-
Mast cells and arteriogenesis: A systematic review.Cardiovasc Pathol. 2025 Mar-Apr;75:107716. doi: 10.1016/j.carpath.2025.107716. Epub 2025 Jan 6. Cardiovasc Pathol. 2025. PMID: 39778667
-
Mechanisms of arteriogenesis.Acta Biochim Biophys Sin (Shanghai). 2008 Aug;40(8):681-92. Acta Biochim Biophys Sin (Shanghai). 2008. PMID: 18685784 Review.
-
Insights into mechanisms behind arteriogenesis: what does the future hold?J Leukoc Biol. 2008 Dec;84(6):1379-91. doi: 10.1189/jlb.0508281. Epub 2008 Aug 4. J Leukoc Biol. 2008. PMID: 18678607 Review.
-
Arteriogenesis requires toll-like receptor 2 and 4 expression in bone-marrow derived cells.J Mol Cell Cardiol. 2011 Jan;50(1):25-32. doi: 10.1016/j.yjmcc.2010.08.006. Epub 2010 Aug 12. J Mol Cell Cardiol. 2011. PMID: 20708624
Cited by
-
miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome.Am J Physiol Heart Circ Physiol. 2015 Jun 1;308(11):H1323-35. doi: 10.1152/ajpheart.00654.2014. Epub 2015 Apr 3. Am J Physiol Heart Circ Physiol. 2015. PMID: 25840830 Free PMC article.
-
Arteriolar and venular remodeling are differentially regulated by bone marrow-derived cell-specific CX3CR1 and CCR2 expression.PLoS One. 2012;7(9):e46312. doi: 10.1371/journal.pone.0046312. Epub 2012 Sep 24. PLoS One. 2012. PMID: 23029475 Free PMC article.
-
Exposure of Endothelium to Biomimetic Flow Waveforms Yields Identification of miR-199a-5p as a Potent Regulator of Arteriogenesis.Mol Ther Nucleic Acids. 2018 Sep 7;12:829-844. doi: 10.1016/j.omtn.2018.08.001. Epub 2018 Aug 8. Mol Ther Nucleic Acids. 2018. PMID: 30153567 Free PMC article.
-
Visceral fat index: a novel predictor for coronary collateral circulation.Arch Endocrinol Metab. 2020 Apr;64(2):150-158. doi: 10.20945/2359-3997000000218. Epub 2020 Mar 27. Arch Endocrinol Metab. 2020. PMID: 32236316 Free PMC article.
-
Laser speckle flowmetry method for measuring spatial and temporal hemodynamic alterations throughout large microvascular networks.Microcirculation. 2012 Oct;19(7):619-31. doi: 10.1111/j.1549-8719.2012.00197.x. Microcirculation. 2012. PMID: 22591575 Free PMC article.
References
-
- Amann B, Ludemann C, Ruckert R, Lawall H, Liesenfeld B, Schneider M, Schmidt-Lucke J. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI) Vasa. 2008;37:319–325. - PubMed
-
- Andrade-Silva AR, Ramalho FS, Ramalho LN, Saavedra-Lopes M, Jordao AA, Jr, Vanucchi H, Piccinato CE, Zucoloto S. Effect of NFkappaB inhibition by CAPE on skeletal muscle ischemia-reperfusion injury. J Surg Res. 2009;153:254–262. - PubMed
-
- Asahara T, Murohara T, Sullivan A, Silver M, van der ZR, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources